All News #Library
Rare Diseases
Blueprint Medicines: Data on AYVAKIT® Treatment at 2025 Congresse
12 Jun 2025 //
PR NEWSWIRE
Sanofi to buy US biopharma group Blueprint for over $9 billion
03 Jun 2025 //
PRESS RELEASE
EC approves treatment for rare haematological disorder
13 Dec 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
Genentech, Blueprint tout full approval for Gavreto in rare type of lung cancer
10 Aug 2023 //
ENDPTS
Cogent touts data on small subset of patients in bid to compete with Blueprint
12 Dec 2022 //
ENDPTS

Market Place
Sourcing Support